GPC3 and hepatocellular carcinoma: Furthermore, IR‐BTOG‐modified BTOGP‐GPC3 nanoparticles (NPs) demonstrate pronounced efficacy in both the diagnosis and photothermal therapy of HCC, providing a novel conceptual and structural foundation for the future development of NIR‐II S‐D‐A‐D‐S type molecules.